United States · What does Ferrer Freeman & Company invest in?
Ferrer Freeman & Company invests most often at Series C (100% of the rounds on record), in sectors such as Wellbeing, Connected-health and Wellness.
Ferrer Freeman & Company highlights
- 01
2 rounds on record
- 02
Mostly Series C: 100% of its rounds
- 03
Sole investor in 1 rounds, median $26M
- 04
1 exits from the portfolio
What they do
- Type
- Private equity (from a list, unverified)
- Cheque size
- Not stated
- Stages
- Growth
- Sectors
- WellbeingConnected-healthWellness
- Based in
- Greenwich, United States
- Cold pitches
- Not stated
The record
Every round we can evidence, newest first2 appearances
- 2008
1 round
- Jan
- 2003
1 round
- Apr
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
Exits from the portfolio
Companies it backed that were later bought or listed1 in all
Xcel PharmaceuticalsBought by Valeant Pharmaceuticals InternationalUndisclosedFeb 2005
An exit counts when it came after the firm's first round in the company. From historical deal records.